Huge funding boost for biomedical research
23 September 2011
Two NHS Trusts in partnership with Imperial have received multi-million pound awards to boost research and enable the development of more effective medicines, treatments and care for patients, it was announced at the end of August. The funding forms part of the UK’s largest ever investment in early-stage health research, which has given an £800 million funding boost to 31 university and NHS partnerships.
Imperial College Healthcare NHS Trust and the College have been given £112 million by the National Institute for Health Research (NIHR), to fund their Biomedical Research Centre (BRC). The award, which will cover five years from April 2012, renews the funding granted to the Trust and the College by the NIHR in 2006 to establish the BRC.
The funding will enable the BRC to continue to carry out research in areas including cancer, diabetes, heart disease, neuroscience, renal medicine and transplantation, paediatrics and women’s health.
Two biomedical research units (BRUs) run jointly by Royal Brompton and Harefield NHS Foundation Trust and Imperial College London were also recognised with a grant of almost £20 million. These two units are at the forefront of international research into the most challenging lung and heart conditions affecting patients around the world.
Sir Keith O’Nions said: “Our partnerships with Imperial College Healthcare NHS Trust and with Royal Brompton and Harefield NHS Trust are hugely important for delivering the outcomes of our medical research to patients, and the scale of these new awards recognises just how successful these partnerships have been.”
— Laura Gallagher, Communications and Development